Lung Cancer Europe shared a post on X:
“The EU is looking at cutting back patient involvement in medicine regulation.
For people with lung cancer, this isn’t just policy – it’s a risk to timely, effective treatment.
‘Shutting patients out would be a huge mistake. When patients are involved, better decisions are made.’ – Debra Montague, VP LuCE.
Lung Cancer Europe stands with EURORDIS – Rare Diseases Europe and European Patients’ Forum. Patient voices must be heard.”
More posts featuring Lung Cancer Europe.